SERA 3.19 (+1.92%)
US81749D1072• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. SERA

Sera Prognostics (SERA) Competitor Comparison

We are evaluating the key criteria listed to compare Sera Prognostics (SERA) against its competitors in the Diagnostics & Research industry.

Market Capitalization

39 / 58

Gross Profits

51 / 52

Total Revenue

54 / 57

EBITDA

43 / 56

Free Cashflow

41 / 56

Quick Ratio

21 / 57

Earnings per Share

36 / 56

Dividend yield

0 / 9

Total Cash

40 / 57

Performance 3 years

13 / 58

Performance 5 years

46 / 58

Performance 10 years

42 / 58

Linearity 3 years

3 / 58

Linearity 5 years

43 / 58

Linearity 10 years

28 / 58

Total Rank

49 / 58

Dividend Rank

33 / 58

Valuation Rank

46 / 58

Piotroski Rank

45 / 58

Muliplier Rank

33 / 58

Linearity 5 years - SERA ranking 43 / 58

These are the competitors of Sera Prognostics in the industry Diagnostics & Research ranked by linearity 5 years
1. Icon ICLR
1.51K
2. Charles River Laboratories CRL
238.77
3. Co-Diagnostics CODX
100.26
4. Qiagen QGEN
61.32
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. DarioHealth DRIO
31.71
7. Syneos Health SYNH
24.79
8. DexCom DXCM
24.56
9. Inotiv NOTV
19.08
10. Heska HSKA
15.42
11. IQVIA Holdings IQV
15.15
12. CareDx CDNA
14.92
13. Pacific Biosciences of California PACB
14.89
14. Fulgent Genetics FLGT
13.1
15. Twist Bioscience TWST
11.47
16. Agilent Technologies A
9.59
17. Anixa Biosciences ANIX
9.16
18. Olink Holding OLK
8.53
19. Thermo Fisher Scientific TMO
7.76
20. Precipio PRPO
7.73
21. Danaher DHR
7.71
22. Mettler-Toledo MTD
7.63
23. Exact Sciences EXAS
7.25
24. Myriad Genetics MYGN
7.05
25. IDEXX Laboratories IDXX
6.06
26. Aspira Womens Health AWH
5.9
27. Guardant Health GH
5.51
28. PerkinElmer PKI
4.97
29. Personalis PSNL
4.95
30. Trinity Biotech TRIB
4.91
31. Psychemedics PMD
4.22
32. Waters WAT
3.77
33. NeoGenomics NEO
3.61
34. Enzo Biochem ENZ
3.59
35. Sotera Health SHC
3.41
36. Illumina ILMN
3.4
37. National Research NRC
3.3
38. Laboratory Corp of America Holdings LH
3.26
39. Neogen NEOG
3.21
40. Bioventus BVS
2.93
41. Quest Diagnostics DGX
2.7
42. Interpace Biosciences IDXG
2.45
43. Sera Prognostics SERA
2.36
44. Exagen XGN
2.31
45. Neuronetics STIM
2.28
46. Global Cord Blood CO
2.23
47. MDxHealth MDXH
1.91
48. Biodesix BDSX
1.8
49. MaxCyte MXCT
1.78
50. Prenetics Global PRE
1.71
51. bioAffinity Technologies BIAF
1.67
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Medpace Holdings MEDP
1.2
55. Meridian Bioscience VIVO
0.99
56. Natera NTRA
0.76
57. RadNet RDNT
0.75
58. Lantheus Holdings LNTH
0.43
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.